Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Interactions between Candida albicans and the human extracellular matrix component tenascin-C.

López-Ribot JL, Bikandi J, San Millán RS, Chaffin WL.

Mol Cell Biol Res Commun. 1999 Jul;2(1):58-63.

PMID:
10527893
2.

The fibrinogen-like globe of tenascin-C mediates its interactions with neurocan and phosphacan/protein-tyrosine phosphatase-zeta/beta.

Milev P, Fischer D, Häring M, Schulthess T, Margolis RK, Chiquet-Ehrismann R, Margolis RU.

J Biol Chem. 1997 Jun 13;272(24):15501-9.

3.
4.

Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth.

Fischer D, Brown-Lüdi M, Schulthess T, Chiquet-Ehrismann R.

J Cell Sci. 1997 Jul;110 ( Pt 13):1513-22.

5.

Alternative splicing in the aggrecan G3 domain influences binding interactions with tenascin-C and other extracellular matrix proteins.

Day JM, Olin AI, Murdoch AD, Canfield A, Sasaki T, Timpl R, Hardingham TE, Aspberg A.

J Biol Chem. 2004 Mar 26;279(13):12511-8. Epub 2004 Jan 13.

6.

Mitogenic and adhesive effects of tenascin-C on human hematopoietic cells are mediated by various functional domains.

Seiffert M, Beck SC, Schermutzki F, Müller CA, Erickson HP, Klein G.

Matrix Biol. 1998 Apr;17(1):47-63.

PMID:
9628252
7.

Tenascin function and regulation of expression.

Vrucinić-Filipi N, Chiquet-Ehrismann R.

Symp Soc Exp Biol. 1993;47:155-62.

PMID:
7513089
8.

Specific processing of tenascin-C by the metalloprotease meprinbeta neutralizes its inhibition of cell spreading.

Ambort D, Brellier F, Becker-Pauly C, Stöcker W, Andrejevic-Blant S, Chiquet M, Sterchi EE.

Matrix Biol. 2010 Jan;29(1):31-42. doi: 10.1016/j.matbio.2009.08.007. Epub 2009 Sep 12.

PMID:
19748582
9.

Tenascin-R (J1 160/180 inhibits fibronectin-mediated cell adhesion--functional relatedness to tenascin-C.

Pesheva P, Probstmeier R, Skubitz AP, McCarthy JB, Furcht LT, Schachner M.

J Cell Sci. 1994 Aug;107 ( Pt 8):2323-33.

10.

Influence of cell surface hydrophobicity on attachment of Candida albicans to extracellular matrix proteins.

Silva TM, Glee PM, Hazen KC.

J Med Vet Mycol. 1995 Mar-Apr;33(2):117-22.

PMID:
7658302
11.
12.
13.
14.

Binding of tenascin-C to soluble fibronectin and matrix fibrils.

Chung CY, Zardi L, Erickson HP.

J Biol Chem. 1995 Dec 1;270(48):29012-7.

15.
16.

A role for Efg1p in Candida albicans interactions with extracellular matrices.

Saville SP, Thomas DP, López Ribot JL.

FEMS Microbiol Lett. 2006 Mar;256(1):151-8.

17.

Adherence of Candida albicans to components of the subendothelial extracellular matrix.

Klotz SA.

FEMS Microbiol Lett. 1990 Mar 15;56(3):249-54.

PMID:
2187740
18.
19.

Binding of contactin/F11 to the fibronectin type III domains 5 and 6 of tenascin is inhibited by heparin.

Weber P, Ferber P, Fischer R, Winterhalter KH, Vaughan L.

FEBS Lett. 1996 Jul 8;389(3):304-8.

20.

Production of fibronectin and tenascin isoforms and their role in the adhesion of human immortalized corneal epithelial cells.

Filenius S, Tervo T, Virtanen I.

Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3317-25.

PMID:
12882776

Supplemental Content

Support Center